Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001035704-03-000173
Filing Date
2003-03-25
Accepted
2003-03-25 17:36:46
Documents
4
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d04257e10vk.htm 10-K 986238
3 EX-23 CONSENT OF DELOITTE & TOUCHE LLP d04257exv23.txt EX-23 710
4 EX-99.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d04257exv99w1.txt EX-99.1 1255
5 EX-99.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER d04257exv99w2.txt EX-99.2 1254
  Complete submission text file 0001035704-03-000173.txt   991478
Mailing Address 2579 MIDPOINT DR FORT COLLINS CO 80525
Business Address 2579 MIDPOINT DR FORT COLLINS CO 80525 3034825868
ATRIX LABORATORIES INC (Filer) CIK: 0000809875 (see all company filings)

EIN.: 841043826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-18231 | Film No.: 03616484
SIC: 2834 Pharmaceutical Preparations